FDA Approves BIMZELX for Psoriasis
Learn more about the approval of a new drug, BIMZELX (bimekizumab-bkzx), for people with moderate to severe plaque psoriasis.
Why LGBTQ+ Representation Matters to Me: Celebrating Diversity and Inclusion in Health Care In honor of LGBTQ+ Pride Month, hear firsthand from members of our chronic illness community about the vital importance of representation for the LGBTQ+ community in achieving…
BLOOD CANCERS LIKE LEUKEMIA MAY LEAD TO MORE SEVERE CASES OF COVID-19 THAN OTHER KINDS OF CANCER